D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 70 Citations 36,912 143 World Ranking 1051 National Ranking 565
Medicine D-index 81 Citations 42,034 193 World Ranking 9064 National Ranking 4914

Research.com Recognitions

Awards & Achievements

2019 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Immune system

His primary areas of study are Immunology, Cancer research, Immune system, Tumor microenvironment and IL-2 receptor. His Immunology study integrates concerns from other disciplines, such as Cytotoxic T cell and Tumor progression. His studies deal with areas such as Carcinogenesis, Cancer stem cell, T cell, Cancer epigenetics and Histone as well as Cancer research.

The concepts of his Immune system study are interwoven with issues in Cancer, Downregulation and upregulation and Cell biology. His Tumor microenvironment study incorporates themes from Blockade and Angiogenesis. Weiping Zou has researched IL-2 receptor in several fields, including Chemokine, Interleukin 21 and FOXP3.

His most cited work include:

  • Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. (3925 citations)
  • Regulatory T cells, tumour immunity and immunotherapy (1660 citations)
  • Immunosuppressive networks in the tumour environment and their therapeutic relevance (1630 citations)

What are the main themes of his work throughout his whole career to date?

Weiping Zou focuses on Cancer research, Immunology, Immune system, Immunotherapy and Cancer. His Cancer research research includes themes of Tumor microenvironment, T cell, CD8, Ovarian cancer and Colorectal cancer. His study ties his expertise on Myeloid-derived Suppressor Cell together with the subject of Immunology.

His studies in Immune system integrate themes in fields like Cytokine, Antigen and Cell biology. His work focuses on many connections between Immunotherapy and other disciplines, such as Immunity, that overlap with his field of interest in Apoptosis. Weiping Zou combines subjects such as Cell and Stem cell with his study of Cancer.

He most often published in these fields:

  • Cancer research (53.25%)
  • Immunology (39.39%)
  • Immune system (36.36%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (53.25%)
  • Immunotherapy (25.97%)
  • Immune system (36.36%)

In recent papers he was focusing on the following fields of study:

Weiping Zou mainly focuses on Cancer research, Immunotherapy, Immune system, T cell and Chemistry. His Cancer research research includes elements of Immune checkpoint, Tumor microenvironment, Cancer, CD8 and Cancer immunotherapy. His study on Metastasis is often connected to Histocompatibility Antigens Class I as part of broader study in Cancer.

His Immunotherapy study combines topics from a wide range of disciplines, such as Dendritic cell, Immunity, SLC7A11, Radiation therapy and Antigen presentation. By researching both Immune system and Methionine, Weiping Zou produces research that crosses academic boundaries. The various areas that Weiping Zou examines in his T cell study include Histone methylation, Ovarian cancer, Epigenetics and Interleukin 17.

Between 2018 and 2021, his most popular works were:

  • CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy (246 citations)
  • Cancer nanomedicine for combination cancer immunotherapy (184 citations)
  • Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11 (88 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Immune system

Weiping Zou mainly investigates Cancer research, Immunotherapy, T cell, Immune system and CD8. Weiping Zou interconnects Immune checkpoint, Downregulation and upregulation, Radiation therapy and Cancer immunotherapy in the investigation of issues within Cancer research. His study in Immunotherapy is interdisciplinary in nature, drawing from both Clinical trial and SLC7A11.

His work investigates the relationship between T cell and topics such as Epigenetics that intersect with problems in Chromatin. His Immune system research integrates issues from Phenotype, Cancer, Ovarian cancer and Adenosine. His Cancer research is multidisciplinary, incorporating elements of Peripheral tolerance and Immune tolerance.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Tyler J Curiel;George Coukos;Linhua Zou;Xavier Alvarez.
Nature Medicine (2004)

5369 Citations

Regulatory T cells, tumour immunity and immunotherapy

Weiping Zou.
Nature Reviews Immunology (2006)

2270 Citations

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Weiping Zou.
Nature Reviews Cancer (2005)

2257 Citations

Inhibitory B7-family molecules in the tumour microenvironment

Weiping Zou;Lieping Chen.
Nature Reviews Immunology (2008)

1553 Citations

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

Weiping Zou;Jedd D. Wolchok;Lieping Chen.
Science Translational Medicine (2016)

1262 Citations

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Tyler J Curiel;Shuang Wei;Haidong Dong;Xavier Alvarez.
Nature Medicine (2003)

1234 Citations

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

Ilona Kryczek;Mousumi Banerjee;Pui Cheng;Linhua Vatan.
Blood (2009)

806 Citations

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells.

Weiping Zou;Weiping Zou;Véronique Machelon;Aurore Coulomb-L'Hermin;Jozef Borvak.
Nature Medicine (2001)

752 Citations

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

Ilona Kryczek;Ilona Kryczek;Linhua Zou;Linhua Zou;Paulo Rodriguez;Gefeng Zhu.
Journal of Experimental Medicine (2006)

736 Citations

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

Nisha Nagarsheth;Max S. Wicha;Weiping Zou.
Nature Reviews Immunology (2017)

735 Citations

Best Scientists Citing Weiping Zou

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 92

George Coukos

George Coukos

University of Lausanne

Publications: 72

Lieping Chen

Lieping Chen

Yale University

Publications: 71

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 67

Alberto Mantovani

Alberto Mantovani

Humanitas University

Publications: 60

Laurence Zitvogel

Laurence Zitvogel

Institut Gustave Roussy

Publications: 59

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 50

Yang-Xin Fu

Yang-Xin Fu

The University of Texas Southwestern Medical Center

Publications: 48

Kunle Odunsi

Kunle Odunsi

Roswell Park Cancer Institute

Publications: 47

Shimon Sakaguchi

Shimon Sakaguchi

Osaka University

Publications: 47

François Ghiringhelli

François Ghiringhelli

Inserm : Institut national de la santé et de la recherche médicale

Publications: 47

Tyler J. Curiel

Tyler J. Curiel

The University of Texas at Austin

Publications: 46

Hiroyoshi Nishikawa

Hiroyoshi Nishikawa

Nagoya University

Publications: 46

Gordon J. Freeman

Gordon J. Freeman

Harvard University

Publications: 45

Theresa L. Whiteside

Theresa L. Whiteside

University of Pittsburgh

Publications: 44

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.